4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-023809
EVP, Global Sales & Marketing sold 34,160 shares at an average $5.02 ($171,616)
- EVP, Global Sales & Marketing acquired 34,160 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ross Thomas M. · EVP, Global Sales & Marketing
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,967 | $2.14 | $14,923 | 6,967 | D |
| 2023-04-05 | Sale : show line 2 in the form 10b5-1 | −6,967 | $5.00 | $34,835 | 0 | D |
| 2023-04-06 | Exercise or conversion : show line 3 in the form 10b5-1 | +27,193 | $2.14 | $58,247 | 27,193 | D |
| 2023-04-06 | Sale : show line 4 in the form 10b5-1 | −27,193 | $5.03 | $136,781 | 0 | D |
| Open-market sales · 34,160 sh · avg $5.02 · $171,616 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-05 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) | −6,967 | 55,195 | D |
| 2023-04-06 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) | −27,193 | 28,002 | D |
Loading xslF345X04/doc4.xml…